Tessera Therapeutics
Biotech tool for writing precise, permanent genetic changes to treat inherited diseases
Funding
$500.00M
2022
Details
Headquarters
Cambridge, United States
Website
Milestones
FOUNDING YEAR
2018
News
The latest coverage and announcements from Tessera Therapeutics.